The treatment of nursing home‐acquired pneumonia using a medically intensive Hospital in the Home service

Abstract

This study suggests that HITH may be an effective and safe alternative to hospital treatment for residents of aged care facilities presenting with NHAP.

Safety and effectiveness of ‘hospital in the home’ and ‘outpatient parenteral antimicrobial therapy’ in different age groups: A systematic review of observational studies

“…Numerous studies assessing the adverse events (AEs) and effectiveness of HITH and OPAT have been performed in many countries including Australia, USA, UK, Spain, France, Singapore, Israel, Canada, Italy, Ireland, New Zealand, Saudi Arabia, Switzerland and Greece . Some studies have analysed the safety of HITH or OPAT for a particular disease or for a particular group including geriatric or paediatric patients …”

Cost‐effectiveness of professional oral health care in Australian residential aged care facilities

“…The global impact of NHAP is sobering: globally there are more than 4 million new cases annually, at a median rate of 1.0‐3.2 cases per 1000 bed‐days and 600 000 emergency admissions . In Australia, permanent RACF residents accounted for 31 760 acute hospital admissions for pneumonia during the 2008‐2009 financial year, with a mean hospital length of stay of 7 days for pneumonia, which amounts to 222 320 hospital bed‐days, or 609 fully occupied hospital beds for patients with NHAP . Taking into account that hospitalisation costs were the most significant expenses in our models, the potential economic impact of preventing NHAP cases would be substantial.…”

“…Therefore, pneumonia treatment in hospital would take longer than in a RACF. The literature indicates a mean stay of 7.0‐18.7 days for hospital treatments and 5 days for RACF treatments …”

“…The literature indicates a mean stay of 7.0-18.7 days for hospital treatments and 5 days for RACF treatments. 10,45 Diagnosis-related group (DRG) codes chosen for pneumonia treatment were as follows:…”

“…RACF residents accounted for 31 760 acute hospital admissions for pneumonia during the 2008-2009 financial year,52 with a mean hospital length of stay of 7 days for pneumonia, which amounts to 222 320 hospital bed-days, or 609 fully occupied hospital beds for patients with NHAP 45. Taking into account that hospitalisation costs were the most significant expenses in our models, the potential economic impact of preventing NHAP cases would be substantial.However, present findings need to be assessed in view of the limitations of this study.…”